Sean McCutcheon
Stock Analyst at Raymond James
(n/a)
# 4,498
Out of 4,842 analysts
5
Total ratings
n/a
Success rate
-47.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENGN enGene Holdings | Initiates: Outperform | $23 | $3.97 | +479.37% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $7.65 | +422.88% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $30.72 | +127.86% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $28.41 | +202.76% | 1 | Mar 13, 2024 |
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $3.97
Upside: +479.37%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $7.65
Upside: +422.88%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $30.72
Upside: +127.86%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $28.41
Upside: +202.76%